EVOEvotec SE
Price
-62%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Nothing alarming, growth steady, the market undecided.
Evotec SE is a publicly listed European stock corporation operating under German law. We have operating sites in Germany, Italy, France, UK and US. The group has been successful in creating both operational and technological synergies between the sites and geographical regions by way of organic growth and strategic acquisitions. A listing of our significant subsidiaries and their jurisdiction of incorporation is included in Exhibit 8.1 to this 20-F filing.
In the company’s own words · 20-F filed Apr 8, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
For the full year FY2025, revenue was €788M (−1.1% year on year) and net income −€104M.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Drug Manufacturers, Specialty & Generic
Ranks #23 of 39 by RyuScore